
浏览全部资源
扫码关注微信
1.中国中医科学院 中医临床基础医学研究所 循证医学基础研究室,北京 100700
2.中国中医药循证医学中心,北京 100700
吴雪,在读博士,从事循证中医药方法学研究工作,E-mail:wuxue19941227@163.com
廖星,博士,研究员,从事中医药循证评价和卫生技术评估研究,E-mail:okfrom2008@hotmail.com
收稿日期:2022-03-08,
网络出版日期:2022-05-17,
纸质出版日期:2022-10-20
移动端阅览
吴雪,徐思敏,戴泽琦等.国内外卫生技术评估机构的概况性综述[J].中国实验方剂学杂志,2022,28(20):178-185.
WU Xue,XU Simin,DAI Zeqi,et al.Health Technology Assessment Institutions and Organizations: A Scoping Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(20):178-185.
吴雪,徐思敏,戴泽琦等.国内外卫生技术评估机构的概况性综述[J].中国实验方剂学杂志,2022,28(20):178-185. DOI: 10.13422/j.cnki.syfjx.20222096.
WU Xue,XU Simin,DAI Zeqi,et al.Health Technology Assessment Institutions and Organizations: A Scoping Review[J].Chinese Journal of Experimental Traditional Medical Formulae,2022,28(20):178-185. DOI: 10.13422/j.cnki.syfjx.20222096.
采用概况性综述的方法,对国际上具有较大影响力的卫生技术评估(HTA)组织、西方发达国家及亚洲部分国家HTA机构的概况进行系统梳理,以了解国内外HTA机构的发展状况,为我国HTA机构的建设与发展提供依据。该研究基于2020—2021年世界卫生组织(WHO)全球HTA的第二轮调查结果,检索WHO官网、国际卫生技术评估数据库(INHTA)、国际HTA机构组织网站与各国HTA相关网站。在提取数据并分类后,本研究对9个国际组织(包括卫生决策中心、国际卫生技术评估协会、亚太卫生技术评估网络、国际卫生技术评估机构网络、欧洲卫生技术评估网络、美洲卫生技术评估网络、国际药物经济学和结果研究学会、非洲南部卫生技术评估学会、国际创新和变革卫生技术信息网)、西方发达国家及亚洲国家共11个(包括加拿大、法国、德国、英国、澳大利亚、美国、日本、马来西亚、韩国、新加坡、泰国)及我国 6个HTA机构/团队的概况进行了总结。本研究发现各国医药卫生体制不同,对HTA的运用差异较大,因而HTA在各国卫生决策方面的作用程度不同。而国际HTA组织大大加强了HTA机构与制药行业之间的交流,推动了循证卫生决策的不断推广和实践。
To understand the development status and provide the basis for the construction and development of health technology assessment (HTA) institutions/organizations in China, this paper systematically reviewed the status of international HTA institutions/organizations and the HTA institutions/organizations in western developed countries and some Asian countries. This study was based on the results of the second round of global survey on HTA conducted by the World Health Organization (WHO) in 2020/2021. The websites of WHO, International HTA Database (INAHTA), international HTA institutions/organizations, and the HTA institutions/organizations in different countries were searched. After data extraction and classification, we summarized the status of 9 international HTA institutions/organizations (including Decide: Health Decision Hub, Health Technology Assessment International, HTAsiaLink, International Network of Agencies for Health Technology Assessment, European Network for Health Technology Assessment, Health Technology Assessment Network of the Americas, International Society for Pharmacoeconomics and Outcomes Research, Southern African Health Technology Assessment Society, International Information Network on New and Emerging Health Technologies), 11 HTA institutions/organizations in western developed countries and Asian countries (including Canada, France, Germany, the United Kingdom, Australia, the United States, Japan, Malaysia, South Korea, Singapore, and Thailand), and 6 HTA organizations/teams in China. The use of HTA varies greatly because of different medical and health systems among different countries, and thus the role of HTA in health decision-making varies among different countries. The international HTA institutions/organizations have greatly strengthened the communication between HTA institutions/organizations and the pharmaceutical industry and facilitated the promotion and practice of evidence-based health decision-making.
O'ROURKE B , OORTWIJN W , SCHULLER T . The new definition of health technology assessment:A milestone in international collaboration [J]. Int J Technol Assess Health Care , 2020 , 36 ( 3 ): 187 - 190 .
WORLD HEALTH ORGANIZATION . Health technology assessment [EB/OL].( 2022-02-28 )[ 2022-03-08 ]. https://www.who.int/medical_devices/assessment/zh/ https://www.who.int/medical_devices/assessment/zh/ .
WORLD HEALTH ORGANIZATION . Health Technology Assessment and Health Benefit Package Survey 2020 / 2021 [EB/OL].( 2021-12-16 )[ 2022-03-08 ]. https://www.who.int/teams/health-systems-governance-and-financing/economic-analysis/health-technology-assessment-and-benefit-package-design/survey-homepage https://www.who.int/teams/health-systems-governance-and-financing/economic-analysis/health-technology-assessment-and-benefit-package-design/survey-homepage .
CHEN Y , BANTA D , TANG Z . Health technology assessment development in China [J]. Int J Technol Assess Health Care , 2009 , 25 ( Suppl 1 ): 202 - 209 .
叶冬炜 , 王莉 , 刘叔文 . 卫生技术评估在欧洲4国的应用及对我国的启示 [J]. 中国药房 , 2022 , 33 ( 1 ): 1 - 6 .
国家卫生健康委员会 . 关于国家卫生计生委卫生发展研究中心承担“国家药物和卫生技术综合评估中心”工作的通知 [EB/OL].( 2018-10-16 )[ 2022-03-08 ]. http://www.nhc.gov.cn/qjjys/s7946/201810/8446e74c71fb4db5811ab8aed59c7d6d.shtml http://www.nhc.gov.cn/qjjys/s7946/201810/8446e74c71fb4db5811ab8aed59c7d6d.shtml .
健康界 . 首届中国卫生技术评估大会在京召开 [EB/OL].( 2018-10-27 )[ 2022-03-08 ]. https://www.cn-healthcare.com/article/20181027/content-509308.html https://www.cn-healthcare.com/article/20181027/content-509308.html .
TRICCO A C , LILLIE E , ZARIN W , et al . PRISMA Extension for scoping reviews (PRISMA-ScR):Checklist and explanation [J]. Ann Intern Med , 2018 , 169 ( 7 ): 467 - 473 .
ANDERSON S , ALLEN P , PECKHAM S , et al . Asking the right questions:Scoping studies in the commissioning of research on the organisation and delivery of health services [J]. Health Res Policy Syst , 2008 , 6 : 7 .
DE CHAVEZ A C , BACKETT-MILBURN K , PARRY O , et al . Understanding and researching wellbeing:Its usage in different disciplines and potential for health research and health promotion [J]. HEJ , 2005 , 64 ( 1 ): 70 - 87 .
DECARIA J E , SHARP C , PETRELLA R J . Scoping review report:Obesity in older adults [J]. Int J Obes (Lond) , 2012 , 36 ( 9 ): 1141 - 1150 .
PETERS M D , GODFREY C M , KHALIL H , et al . Guidance for conducting systematic scoping reviews [J]. Int J Evid Based Healthc , 2015 , 13 ( 3 ): 141 - 146 .
王娟 , 韩旭 , 姜淼 , 等 . 口服中成药治疗肺癌临床研究证据的概况性综述 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 8 ): 204 - 213 .
毛莉 , 唐健元 , 廖星 . 口服中成药治疗乳腺癌临床研究证据的概况性综述 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 8 ): 231 - 238 .
庞晴 , 杨亚男 , 吴倩 , 等 . 口服中成药治疗高脂血症临床研究证据的概况性综述 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 8 ): 214 - 221 .
李苗苗 , 吴雪 , 徐思敏 , 等 . 快速卫生技术评估的概况性综述 [J]. 中国中药杂志 , 2022 , 47 ( 12 ): 3125 - 3135 .
徐思敏 , 戴泽琦 , 吴雪 , 等 . 国内外医院卫生技术评估的概况性综述 [J]. 中国中药杂志 , 2022 , 47 ( 12 ): 3136 - 3143 .
石霞 , 张海艳 , 苗青 , 等 . 口服中成药治疗流行性感冒临床研究证据的概况性综述 [J]. 中国实验方剂学杂志 , 2022 , 28 ( 8 ): 222 - 230 .
WORLD HEALTH ORGANIZATION . HTA Country/Area Profiles [EB/OL].( 2021-12-16 )[ 2022-03-08 ]. https://cdn.who.int/media/docs/default-source/health-economics/hta-country-profiles-2020-21/hta_updated_merged_final.pdf?sfvrsn=75ac91f6_5 https://cdn.who.int/media/docs/default-source/health-economics/hta-country-profiles-2020-21/hta_updated_merged_final.pdf?sfvrsn=75ac91f6_5 .
INTERNATIONAL NETWORK OF AGENCIES FOR HEALTH TECHNOLOGY ASSESSMENT . INAHTA Members List [EB/OL].( 2022-02-09 )[ 2022-03-08 ]. https://www.inahta.org/members/members_list/ https://www.inahta.org/members/members_list/ .
SOUTHERN AFRICAN HEALTH TECHNOLOGY ASSESSMENT SOCIETY . HTA organizations [EB/OL].( 2022-02-09 )[ 2022-03-08 ]. https://www.htasa.org.za/hta-organizations/ https://www.htasa.org.za/hta-organizations/ .
NICE TRIENNIAL REVIEW TEAM , ASSURANCE DIVISION , GROUP OPERATIONS , et al . Report of the triennial review of the national institute for health and care excellence [R]. London : Department of Health , 2015 .
房良 , 王海银 , 程文迪 , 等 . 日本卫生技术评估机制建设研究与启示 [J]. 卫生软科学 , 2019 , 33 ( 5 ): 9 - 13,16 .
KIM L , KIM J A , KIM S . A guide for the utilization of Health insurance review and assessment service national patient samples [J]. Epidemiol Health , 2014 , doi: 10.4178/epih/e2014008 http://dx.doi.org/10.4178/epih/e2014008 .
AHN J , KIM G , SUH H S , et al . Social values and healthcare priority setting in Korea [J]. J Health Organ Manag , 2012 , 26 ( 3 ): 343 - 350 .
王怡 , 陈嘉珩 , 胡秀静 , 等 . 不同国家卫生技术评估应用现状及对“健康中国”建设启示 [J]. 中国公共卫生 , 2021 , 37 ( 11 ): 1713 - 1717 .
程文迪 , 孙辉 , 房良 , 等 . 泰国卫生技术评估机制建设现状及启示 [J]. 中国卫生质量管理 , 2020 , 27 ( 1 ): 109 - 113 .
0
浏览量
22
下载量
2
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备11010802024621